Jay Green, PGY-4 Dr. Jason Lord August 20, 2009. Dr. Jason Lord Dr. Dan Howes Dr. Trevor Langhan ...

Preview:

Citation preview

Jay Green, PGY-4Dr. Jason Lord

August 20, 2009

Dr. Jason Lord Dr. Dan Howes Dr. Trevor Langhan Dr. Aric Storck

Case Definitions Keys to sepsis management

Why is sepsis important?

SIRS (2 of)T<36 or >38HR>90RR>20, pCO2 < 32WBC<4, >12 or >10% bands

SIRS Sepsis Severe sepsis Septic shock

Sepsis Management

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

Mortality: 46%

SEVERE SEPSIS

SEPTIC SHOCK

SEPSIS

SIRS

Mortality: 10%

Mortality: 16%

You think he’s septic ?Pulmonary source?

Sepsis Management

1. RecognitionSIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

#1 priority in sepsis?

Kumar et al. Crit Care Med 2006;34(6):1589

Kumar et al. Crit Care Med 2006;34(6):1589

Abx keys• Get them in fast!• Culture first• Source control• ?MRSA/

pseudomonas

Chest Levo + ceftriaxone Azithro + ceftriaxone Tazo/Cipro (nursing home, etc)

Abdo Pip/tazo or AGF or ceftriaxone/Flagyl

GU Gent or ceftriaxone

Skin Ancef +/- vanco

Head Ceftriazone + vanco + dex

Surviving Sepsis Campaign• Crit Care Med 2008;36(1):296

CAEP• CJEM 2008 Sept;10(5):443

Sepsis Management

1. Recognition

2. ABX!

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

What does our patient have?

Investigations? Initial management priorities?

Reassess our patient Why is lactate important?

Mortality: 46%

SEVERE SEPSIS

SEPTIC SHOCK

SEPSIS

SIRS

Mortality: 10%

Mortality: 16%

EGDT Mortality: 30%

EGDT

In-hospital mortality• 46.5% vs 30.5% (NNT = 6!)

60-day mortality• 56.9% vs 44.3%

EGDT got more early fluid, pRBC, inotropes

Hinshaw & Cox. The Fundamental Mechanisms in Shock. Plenum Press, New York. 1972. Hypovolemi

c Distributive Cardiogenic Obstructive

✓✓✓

Hypovolemic

Distributive

Cardiogenic

Why are patients in hypovolemic shock?• Venodilation• 3rd spacing• Losses (vomiting, diaphoresis)• Recent poor PO intake

Crystalloid vs colloid?

BMJ 1998;316:961

NEJM 2004;350:2247

Cochrane review, 2005 VISEP. NEJM 2008;358:125-39 NS – cheap, available – USE IT

Surviving Sepsis Campaign• Colloid or crystalloid

CAEP• Colloid or crystalloid

Crit Care Med 2008;36(1):296

Voluven• Lu et al. 2009 Mar;21(3):143-6

?lung-protective in rabbits• Palumbo et al. 2006;72(7-8):655

Improved hemodynamics and APACHE-II score• Franziska et al. 2009;35(9):1539

Similar rates of ARF as albumin in surgical ICU pts

Sepsis Management

1. Recognition (lactate, u/o)

2. ABX

3. EGDT (NNT=6)

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

EGDTCVP 8-12 Crystalloid (1L q30min)

Distributive

Should we use vasopressin in sepsis?

NEJM 2008;358(9)

Sepsis Management

1. Recognition (lactate, u/o)

2. ABX

3. EGDT (NNT=6)

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

EGDTCVP 8-12 Crystalloid (1L q30min)

MAP > 65 NE 0.1-2ug/kg/min OR dopamine 5-20ug/kg/min

Cardiogenic

EGDT• If ScvO2<70% and hct<0.30

TRICC • If Hb > 70g/L

How does this help?

O2 content = (1.34 x Hb x SaO2) + (0.0031 x PO2)

NEJM 1999;340:409

Results• No difference in 30 or 60 day mortality• Restrictive group

• Lower in-hospital mortality 22.2% vs 28.1% (p=0.005)

• Less sick pts (APACHE II score <20) did better• ARR 7.4% (95%CI 1.0 – 13.6%)

• No difference in mortality in sepsis sub-group

EGDT• Hypovolemic ED patients• Actual measurement of suboptimal O2

delivery TRICC

• Euvolemic pts enrolled within 72 hours of ICU admit

• 6% sepsis, 27% had any infection

Sepsis Management

1. Recognition (lactate, u/o)

2. ABX

3. EGDT (NNT=6)

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

EGDTCVP 8-12 Crystalloid (1L q30min)

MAP > 65 NE 0.1-2ug/kg/min OR dopamine 5-20ug/kg/min

ScvO2 > 70% pRBC (hct>0.30) dob 2-20ug/kg/min

Absalom 1999, Malerba 2005, Vinclair 2007• Single dose inhibits cortisol synthesis for 24-48h

Mohammed 2006, Ray 2007, Riche 2007• Studies designed for etomidate vs no etomidate• No increase in mortality

CORTICUS (2008)• >28d mort with one dose (OR 1.53 (1.06-2.26)) • Etomidate non-randomized, post-hoc analysis

Bottom line• Avoid in sepsis

NEJM 2000;342(18)

Sepsis Management

1. Recognition (lactate, u/o)

2. ABX

3. EGDT (NNT=6)

4. ARDS vent settings (NNT=11)

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

EGDTCVP 8-12 Crystalloid (1L q30min)

MAP > 65 NE 0.1-2ug/kg/min OR dopamine 5-20ug/kg/min

ScvO2 > 70% pRBC (hct>0.30) dob 2-20ug/kg/min

ARDSNetTV 6cc/kgPEEPPplateau<30

Early studies - no benefit NEJM 1987; 317: 659-65, NEJM 1987; 317: 653-58

Increased mortality at higher doses Crit Care Med. 1995; 23: 1430-39

Annane – benefit in non-responders JAMA 2002;288(7)

CORTICUS – no benefit NEJM 2008;358(2)

Annane - benefit in subgroup JAMA 2009 June;301(22)

Sepsis Management

1. Recognition (lactate, u/o)

2. ABX

3. EGDT (NNT=6)

4. ARDS vent settings (NNT=11)

5. ?Hydrocortisone 50mg q6h -vasopressor-unresponsive pts

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

EGDTCVP 8-12 Crystalloid (1L q30min)

MAP > 65 NE 0.1-2ug/kg/min OR dopamine 5-20ug/kg/min

ScvO2 > 70% pRBC (hct>0.30) dob 2-20ug/kg/min

ARDSNetTV 6cc/kgPEEPPplateau<30

Van den Berghe et al. NEJM 2001;345(19)• Overall mortality benefit

Glucontrol. Presented Oct 2007 • Stopped early, hypoglycemia, protocol violations

VISEP. NEJM 2008;358:125-39• Stopped early, hypoglycemia concerns

Guidelines• SSC – Glucose management in ICU• CAEP – Reasonable to target glu 4-8mmol/L

Sepsis Management

1. Recognition (lactate, u/o)

2. ABX

3. EGDT (NNT=6)

4. ARDS vent settings (NNT=11)

5. Hydrocortisone 50mg q6h -vasopressor-unresponsive pts

6. ?Insulin (ICU unless v. high)

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

EGDTCVP 8-12 Crystalloid (1L q30min)

MAP > 65 NE 0.1-2ug/kg/min OR dopamine 5-20ug/kg/min

ScvO2 > 70% pRBC (hct>0.30) dob 2-20ug/kg/min

ARDSNetTV 6cc/kgPEEPPplateau<30

PROWESS. NEJM 2001;344(10)• Improved survival, NNT = 6

Post-hoc PROWESS. Int Care Med 2003;29• PROWESS benefit only in very sick

ADDRESS. NEJM 2005; 353:13• Stopped early, no effect, increased bleeding

RESOLVE. Lancet 2007;369:836• Peds, no difference in any outcome

Cochrane review 2008 BOTTOM LINE: Not for ED use

Sepsis Management

1. Recognition (lactate, u/o)

2. ABX

3. EGDT (NNT=6)

4. ARDS vent settings (NNT=11)

5. ?Hydrocortisone 50mg q6h -vasopressor-unresponsive pts

6. ?Insulin (BG~10)

7. ?APC (maybe in ICU)

SIRST<36 or >38HR>90RR>20, pCO2<32WBC<4, >12 or >10% bands

EGDTCVP 8-12 Crystalloid (1L q30min)

MAP > 65 NE 0.1-2ug/kg/min OR dopamine 5-20ug/kg/min

ScvO2 > 70% pRBC (hct>0.30) dob 2-20ug/kg/min

ARDSNetTV 6cc/kgPEEPPplateau<30

Recommended